Cargando…

Tumour‐derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8‐mediated creatine import in NPM1‐mutated acute myeloid leukaemia

Acute myeloid leukaemia (AML) carrying nucleophosmin (NPM1) mutations has been defined as a distinct entity of acute leukaemia. Despite remarkable improvements in diagnosis and treatment, the long‐term outcomes for this entity remain unsatisfactory. Emerging evidence suggests that leukaemia, similar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Meixi, Ren, Jun, Jing, Yipei, Jiang, Xueke, Xiao, Qiaoling, Huang, Junpeng, Tao, Yonghong, Lei, Li, Wang, Xin, Yang, Zailin, Yang, Zesong, Zhan, Qian, Lin, Can, Jin, Guoxiang, Zhang, Xian, Zhang, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607980/ https://www.ncbi.nlm.nih.gov/pubmed/34807526 http://dx.doi.org/10.1002/jev2.12168

Ejemplares similares

Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3
por: Jing, Yipei, et al.
Publicado: (2021)

Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia
por: Ren, Jun, et al.
Publicado: (2022)

Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells
por: Huang, Junpeng, et al.
Publicado: (2023)

Mutant NPM1-Regulated FTO-Mediated m(6)A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis
por: Xiao, Qiaoling, et al.
Publicado: (2022)

Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia
por: Xiao, Qiaoling, et al.
Publicado: (2022)

Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia
por: Wang, Lu, et al.
Publicado: (2019)

Up-regulation of EMT-related gene VCAN by NPM1 mutant-driven TGF-β/cPML signalling promotes leukemia cell invasion
por: Yang, Liyuan, et al.
Publicado: (2019)

INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia
por: Jin, Hongjun, et al.
Publicado: (2018)

Treatment efficacy of high‐dose creatine supplementation in a child with creatine transporter (SLC6A8) deficiency
por: Shi, Kaili, et al.
Publicado: (2021)

Creatine transporter (SLC6A8) knockout mice display an increased capacity for in vitro creatine biosynthesis in skeletal muscle
por: Russell, Aaron P., et al.
Publicado: (2014)

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels
por: Kurth, Isabel, et al.
Publicado: (2021)

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
por: Chen, Xue, et al.
Publicado: (2019)

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
por: Huet, Sarah, et al.
Publicado: (2013)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2019)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
por: Skelton, Matthew R., et al.
Publicado: (2011)

Cup‐like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations
por: Ohya, Eiko, et al.
Publicado: (2021)

Studies of structural determinants of substrate binding in the Creatine Transporter (CreaT, SLC6A8) using molecular models
por: Colas, Claire, et al.
Publicado: (2020)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report
por: Wang, Qin, et al.
Publicado: (2018)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

A novel SLC6A8 mutation associated with motor dysfunction in a child exhibiting creatine transporter deficiency
por: Cervera-Acedo, Cristina, et al.
Publicado: (2015)

Creatine uptake regulates CD8 T cell antitumor immunity
por: Di Biase, Stefano, et al.
Publicado: (2019)

NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells
por: Zou, Qin, et al.
Publicado: (2017)

CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport
por: Tian, Cheng, et al.
Publicado: (2023)

DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia
por: Bailey, Graham D., et al.
Publicado: (2019)

SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress
por: Li, Qiao, et al.
Publicado: (2021)

Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia
por: Mahmood, Rafia, et al.
Publicado: (2019)

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
por: Issa, Ghayas C., et al.
Publicado: (2023)

Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
por: Tao, Yao, et al.
Publicado: (2020)

Chronic Myeloid Leukaemia and Blastic Crisis. Series Haematologia, Vol. 8
por: Crowther, D.
Publicado: (1977)

Significance of nucleophosmin1 (NPM1) gene mutation status on acute myeloid leukaemia patients with normal karyotype in South India
por: Sureshkumar, R, et al.
Publicado: (2014)

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
por: Hartmann, Luise, et al.
Publicado: (2016)

Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?
por: Chin, Paulynn Suyin, et al.
Publicado: (2020)

The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia
por: Dickson, Glenda J., et al.
Publicado: (2015)

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia
por: Tiong, Ing S., et al.
Publicado: (2020)

Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience
por: Borlenghi, Erika, et al.
Publicado: (2022)

Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species
por: WEI, CHUNMEI, et al.
Publicado: (2015)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
por: Sorcini, D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q7ic525i9a2006fjqku1b29l7d